NHSA to deliver Chancellor’s £20m funded “Connected Health Cities”
18 March 2015 | By Victoria White
The Chancellor has announced £20 million in the Budget to fund Connected Health Cities projects, to be delivered by NHSA...
List view / Grid view
News
Pharmalink acquires novel therapeutic product candidate for treating inflammation associated with osteoarthritis
18 March 2015 | By
Pharmalink AB announces that it has acquired a novel product candidate in development for treating inflammation from Synartro AB...
HORIBA Scientific Introduces New Back-and Front- Illuminated Synapse EMCCD Camera
18 March 2015 | By HORIBA Scientific
HORIBA Scientific, global leader in Optical Spectroscopy systems, launched its new Synapse EM, a deep cooled EMCCD Scientific camera for low light and ultra-fast spectroscopy experiments...
Zetium: Detail on industry specific editions
18 March 2015 | By PANalytical
Zetium is a unique X-ray fluorescence (XRF) instrument, with up to three complementary technologies on one multi-functional platform...
US Asthma Treatment Market Value to Hit $14 Billion by 2020, says GBI Research
18 March 2015 | By Victoria White
GBI Research reports that the US asthma treatment market value will increase from $11.7 billion in 2013 to an estimated $14 billion...
Novartis receives EU approval for Jakavi ®, the first targeted therapy approved for patients with the rare blood cancer polycythemia vera
18 March 2015 | By Victoria White
Novartis announce that the EU has approved Jakavi ® for the treatment of adult patients with polycythemia vera (PV)...
US Pharmaceutical Market Value Will Approach $550 Billion by 2020, says GlobalData
18 March 2015 | By Victoria White
The US pharmaceutical market is forecast to increase to $548.4 billion by 2020 according to research and consulting firm GlobalData...
Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities
18 March 2015 | By Shimadzu
Shimadzu Scientific Instruments has introduced two new integrated liquid chromatography systems, Prominence-i and Nexera-i, adding to the company’s extensive line-up of HPLC and UHPLC systems...
Many AF patients at high risk of stroke fail to receive guideline-recommended oral anticoagulant treatment
17 March 2015 | By Victoria White
AF patients considered at high risk for stroke may not be receiving recommended treatment as revealed in analyses from the GLORIA™-AF Registry Program...
World Health Organisation (WHO) joins with ESCMID to fight global infections
17 March 2015 | By Victoria White
ESCMID has joined the World Health Organisation (WHO) to launch the 7th annual ‘International Day for Fighting Infection’ on April 24th, 2015...
Waters Transforms Glycan Analysis with New UPLC and UPLC-MS Analytical Workflows
17 March 2015 | By Waters
New RapiFluor-MS Labeling Reagent & Sample Preparation Protocol Enhances Speed, Sensitivity, Simplicity of Released N-Glycan Profiling & Characterization...
New global study on Acute Kidney Injury (AKI) shows the way to eliminating preventable deaths by 2025 – early detection and management are key
16 March 2015 | By The International Society of Nephrology
The International Society of Nephrology (ISN) will present the findings of a new global study on Acute Kidney Injury (AKI), seen by experts as a key step forward in their efforts to eliminate preventable deaths from the condition by 2025 (0by25)...
UK life sciences industry sees resurgent financing year
16 March 2015 | By BioTrinity / Peel Hunt
New research from BioTrinity and Peel Hunt shows $2.9bn raised in 2014...
CAMO Software User Meeting 2015 to take place in Prague
CAMO Software will be arranging their 2015 User Meeting in Prague, Czech Republic on 16th – 17th April...
Actavis receives FDA approval of SAPHRIS® for pediatric patients (age 10-17) for acute treatment of manic or mixed episodes of bipolar I disorder
13 March 2015 | By Actavis
Actavis plc announced that the U.S. Food and Drug Administration has approved its supplemental new drug application (sNDA) for SAPHRIS® (asenapine) as monotherapy for the acute treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients...
